{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:07:21Z","timestamp":1777712841789,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ejpn.2012.04.005","type":"journal-article","created":{"date-parts":[[2012,5,30]],"date-time":"2012-05-30T18:31:12Z","timestamp":1338402672000},"page":"676-682","source":"Crossref","is-referenced-by-count":36,"title":["Neurological manifestations of TB-IRIS: A report of 4 children"],"prefix":"10.1016","volume":"16","author":[{"given":"Ronald","family":"van Toorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Dramowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan F.","family":"Schoeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejpn.2012.04.005_bib1","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/598988","article-title":"Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series","volume":"48","author":"Pepper","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ejpn.2012.04.005_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ejpn.2012.04.005_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAD.0b013e328011981a","article-title":"A presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis","volume":"21","author":"Dautremer","year":"2007","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.ejpn.2012.04.005_bib4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/apc.2006.0085","article-title":"Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma","volume":"21","author":"Lee","year":"2007","journal-title":"AIDS Patient Care STDS"},{"issue":"15","key":"10.1016\/j.ejpn.2012.04.005_bib5","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjies","year":"2010","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.ejpn.2012.04.005_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-8-1","article-title":"Clinical presentation and outcome of tuberculosis in human immunedeficiency virus infected children on antiretroviral therapy","volume":"1","author":"Walters","year":"2008","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.ejpn.2012.04.005_bib7","first-page":"65","article-title":"Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children","volume":"25","author":"van der Weert","year":"2006","journal-title":"PIDJ"},{"issue":"6","key":"10.1016\/j.ejpn.2012.04.005_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/COH.0b013e32833ed774","article-title":"Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesis","volume":"5","author":"Sereti","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"5","key":"10.1016\/j.ejpn.2012.04.005_bib9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1183\/09031936.00091010","article-title":"Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome","volume":"37","author":"Tadokera","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejpn.2012.04.005_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/QAD.0b013e3282f4a607","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study","volume":"22","author":"Murdoch","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ejpn.2012.04.005_bib11","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.ejpn.2012.04.005_bib12","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1097\/QAD.0b013e328340fe76","article-title":"Central nervous system disorders after starting ART in South Africa","volume":"24","author":"Asselman","year":"2010","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ejpn.2012.04.005_bib13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/clinids\/19.6.1092","article-title":"Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review","volume":"19","author":"Afghani","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejpn.2012.04.005_bib14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculous therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ejpn.2012.04.005_bib15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/cir230","article-title":"Timing of initiation of antiretroviral therapy in human immunodeficiency virus-associated tuberculous meningitis","volume":"52","author":"Torok","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ejpn.2012.04.005_bib16","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/cid\/cir239","article-title":"Poor prognosis of HIV-associated Tuberculous meningitis regardless of timing of antiretroviral therapy","volume":"52","author":"Lawn","year":"2011","journal-title":"CID"},{"issue":"4","key":"10.1016\/j.ejpn.2012.04.005_bib17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/088307380401900402","article-title":"Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study","volume":"19","author":"Schoeman","year":"2004","journal-title":"J Child Neurol"},{"issue":"7","key":"10.1016\/j.ejpn.2012.04.005_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0883073809350507","article-title":"Tuberculous meningitis-related optic neuritis: recovery of vision with thalidomide in 4 consecutive cases","volume":"257","author":"Schoeman","year":"2010","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.ejpn.2012.04.005_bib19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s003810000427","article-title":"Possible role of adjunctive thalidomide therapy in the resolution of a massive intracranial tuberculous abscess","volume":"17","author":"Schoeman","year":"2001","journal-title":"Childs Nerv Sust"},{"issue":"3","key":"10.1016\/j.ejpn.2012.04.005_bib20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00126334-200407010-00009","article-title":"Effect of Mycophenolate Mofetil on immune response and plasma and lymphatic tissue viral load during and after interruption of highly active antiretroviral therapy for patients with chronic HIV infection: a randomized pilot study","volume":"36","author":"Garcia","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.ejpn.2012.04.005_bib21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2567.2003.01635.x","article-title":"Mycophenolic acid is a potent inhibitor of the expression of tumour necrosis factor and tumour necrosis factor-receptor superfamily costimulatory molecules","volume":"109","author":"van Rijen","year":"2003","journal-title":"Immunology"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379812000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379812000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,16]],"date-time":"2022-01-16T13:33:46Z","timestamp":1642340026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379812000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1090379812000955"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2012.04.005","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}